If cannepil has been approved to be used on the SAS through the authorised prescriber then it certainly is a significant development.
I would assume that it’s approval could only be achieved with the full GMP process having being completed.
I would also assume that if it obtains TGA approval then it must carry some weight in Europe.
This is a very interesting time for MXC....
If cannepil has been approved to be used on the SAS through the...
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.015(3.80%) |
Mkt cap ! $17.20M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.0¢ | $2.163K | 5.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4763 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 52 | 1 |
View Market Depth
| Last trade - 15.42pm 08/05/2024 (20 minute delay) ? |
| RGT (ASX) Chart |